{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T19:37:28Z","timestamp":1771529848199,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11596-024-2884-0","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T04:01:59Z","timestamp":1718856119000},"page":"545-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TOPK Inhibition Enhances the Sensitivity of Colorectal Cancer Cells to Radiotherapy by Reducing the DNA Damage Response"],"prefix":"10.1007","volume":"44","author":[{"given":"Shi-gui","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-fei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-ze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-mei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong-lan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-juan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"issue":"4","key":"2884_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1158\/2326-6066.CIR-19-0282","volume":"8","author":"B Chen","year":"2020","unstructured":"Chen B, Alarado DM, Iticovici M, et al. Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer. Cancer Immunol Res, 2020,8(4):451\u2013464","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"2884_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 2021,71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2884_CR3","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.tranon.2021.101174","volume":"14","author":"Y Xi","year":"2021","unstructured":"Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol, 2021,14(10):101174","journal-title":"Transl Oncol"},{"issue":"1","key":"2884_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13046-019-1405-7","volume":"38","author":"SY Park","year":"2019","unstructured":"Park SY, Lee CJ, Choi JH, et al. The JAK2\/STAT3\/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance. J Exp Clin Cancer Res, 2019,38(1):399","journal-title":"J Exp Clin Cancer Res"},{"issue":"10207","key":"2884_CR5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet, 2019,394(10207):1467\u20131480","journal-title":"Lancet"},{"issue":"1","key":"2884_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, MillerI KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019,69(1):7\u201334","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2884_CR7","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1073\/pnas.090102397","volume":"97","author":"S Gaudet","year":"2000","unstructured":"Gaudet S, Branton D, Lue RA. Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl Acad Sci U S A, 2000,97(10):5167\u20135172","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"28","key":"2884_CR8","doi-asserted-by":"publisher","first-page":"21525","DOI":"10.1074\/jbc.M909629199","volume":"275","author":"Y Abe","year":"2000","unstructured":"Abe Y, Matsumoto S, Kito K, et al. Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem, 2000,275(28):21525\u201321531","journal-title":"J Biol Chem"},{"issue":"11","key":"2884_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41419-018-1131-7","volume":"9","author":"KJ Herbert","year":"2018","unstructured":"Herbert KJ, Ashton TM, Prevo R, et al. T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics. Cell Death Dis, 2018,9(11):1089","journal-title":"Cell Death Dis"},{"issue":"18","key":"2884_CR10","doi-asserted-by":"publisher","first-page":"9186","DOI":"10.1158\/0008-5472.CAN-06-1601","volume":"66","author":"JH Park","year":"2006","unstructured":"Park JH, Lin ML, Nishidate T, et al. PDZ-binding kinase\/T-LAK cell-originated protein kinase, a putative cancer\/testis antigen with an oncogenic activity in breast cancer. Cancer Res, 2006,66(18):9186\u20139195","journal-title":"Cancer Res"},{"issue":"17","key":"2884_CR11","doi-asserted-by":"publisher","first-page":"15594","DOI":"10.18632\/oncotarget.3709","volume":"6","author":"JD Brown-clay","year":"2015","unstructured":"Brown-clay JD, Shenoy DN, Timofeeva O, et al. PBK\/TOPK enhances aggressive phenotype in prostate cancer via beta-catenin-TCF\/LEF-mediated matrix metalloproteinases production and invasion. Oncotarget, 2015,6(17):15594\u201315609","journal-title":"Oncotarget"},{"issue":"2","key":"2884_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/bjc.2016.394","volume":"116","author":"T Ohashi","year":"2016","unstructured":"Ohashi T, Komastu S, Ichikawa D, et al. Overexpression of PBK\/TOPK relates to tumor malignant potential and poor outcome of gastric carcinoma. Br J Cancer, 2016,116(2):218\u2013226","journal-title":"Br J Cancer"},{"issue":"12","key":"2884_CR13","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.21873\/anticanres.11244","volume":"36","author":"T Ohashi","year":"2016","unstructured":"Ohashi T, Komatsu S, Ichikawa D, et al. Overexpression of PBK\/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma. Anticancer Res, 2016,36(12):6457\u20136466","journal-title":"Anticancer Res"},{"issue":"1","key":"2884_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12957-022-02769-x","volume":"20","author":"L Qiao","year":"2022","unstructured":"Qiao L, Ba J, Xie J, et al. Overexpression of PBK\/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis. World J Surg Oncol, 2022,20(1):316","journal-title":"World J Surg Oncol"},{"issue":"5","key":"2884_CR15","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1006\/bcmd.2001.0452","volume":"27","author":"M Simons-evelyn","year":"2001","unstructured":"Simons-evelyn M, Bailey-dell K, Toretsky JA, et al. PBK\/TOPK is a novel mitotic kinase which is upregulated in Burkitt\u2019s lymphoma and other highly proliferative malignant cells. J Blood Cells Mol Dis, 2001,27(5):825\u2013829","journal-title":"J Blood Cells Mol Dis"},{"issue":"1","key":"2884_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.gastro.2007.04.048","volume":"133","author":"F Zhu","year":"2007","unstructured":"Zhu F, Zykova TA, Kang BS, et al. Bidirectional signals transduced by TOPK-ERK interaction increase tumorigenesis of HCT116 colorectal cancer cells. Gastroenterology, 2007,133(1):219\u2013231","journal-title":"Gastroenterology"},{"key":"2884_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ebiom.2017.04.003","volume":"18","author":"TA Zykova","year":"2017","unstructured":"Zykova TA, Zhu F, Wang L, et al. The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis. EBioMedicine, 2017,18:73\u201382","journal-title":"EBioMedicine"},{"issue":"6","key":"2884_CR18","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.18632\/oncotarget.6826","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Yang Z, Li W, et al. TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun. Oncotarget, 2016,7(6):6748\u20136764","journal-title":"Oncotarget"},{"issue":"2","key":"2884_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11060-018-03051-5","volume":"141","author":"BS Kruthika","year":"2018","unstructured":"Kruthika BS, Jain R, Arivazhagan A, et al. Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma. J Neurooncol, 2018,141(2):315\u2013325","journal-title":"J Neurooncol"},{"issue":"2","key":"2884_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.tranon.2019.09.011","volume":"13","author":"P Mao","year":"2020","unstructured":"Mao P, Bao G, Wang YC, et al. PDZ-Binding Kinase-Dependent Transcriptional Regulation of CCNB2 Promotes Tumorigenesis and Radio-Resistance in Glioblastoma. Transl Oncol, 2020,13(2):287\u2013294","journal-title":"Transl Oncol"},{"issue":"7","key":"2884_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s12276-022-00809-w","volume":"54","author":"H Ma","year":"2022","unstructured":"Ma H, Qi G, Han F, et al. PBK drives PARP inhibitor resistance through the TRIM37\/NFkappaB axis in ovarian cancer. Exp Mol Med, 2022,54(7):999\u20131010","journal-title":"Exp Mol Med"},{"issue":"5","key":"2884_CR22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/2211-5463.12855","volume":"10","author":"JH Park","year":"2020","unstructured":"Park JH, Park SA, Lee YJ, et al. PBK attenuates paclitaxel-induced autophagic cell death by suppressing p53 in H460 non-small-cell lung cancer cells. FEBS Open Bio, 2020,10(5):937\u2013950","journal-title":"FEBS Open Bio"},{"issue":"10","key":"2884_CR23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41419-019-2020-4","volume":"10","author":"JJ Xiao","year":"2019","unstructured":"Xiao JJ, Wang F, Lu H, et al. Targeting the COX2\/MET\/TOPK signaling axis induces apoptosis in gefitinib-resistant NSCLC cells. Cell Death Dis, 2019,10(10):777","journal-title":"Cell Death Dis"},{"issue":"4","key":"2884_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/bjc.2017.197","volume":"117","author":"G Pirovano","year":"2017","unstructured":"Pirovano G, Ashton TM, Herbert KJ, et al. TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy. Br J Cancer, 2017,117(4):503\u2013512","journal-title":"Br J Cancer"},{"issue":"8","key":"2884_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/bies.20085","volume":"26","author":"JC Ame","year":"2004","unstructured":"Ame JC, Spenlehauer C, Murcia GD. The PARP superfamily. Bioessays, 2004,26(8):882\u2013893","journal-title":"Bioessays"},{"issue":"15","key":"2884_CR26","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1080\/15384101.2016.1191250","volume":"15","author":"SK Bharti","year":"2016","unstructured":"Bharti SK, Brosh RM. Fine-tuning DNA repair by protein acetylation. Cell Cycle, 2016,15(15):1952\u20131953","journal-title":"Cell Cycle"},{"issue":"3","key":"2884_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0092-8674(00)81175-7","volume":"93","author":"JP Carney","year":"1998","unstructured":"Carney JP, Maser RS, Olivares H, et al. The hMre11\/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell, 1998,93(3):477\u2013486","journal-title":"Cell"},{"issue":"38","key":"2884_CR28","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1038\/sj.onc.1206893","volume":"22","author":"Y Habraken","year":"2003","unstructured":"Habraken Y, Jolois O, Piette J. Differential involvement of the hMRE11\/hRAD50\/NBS1 complex, BRCA1 and MLH1 in NF-kappaB activation by camptothecin and X-ray. Oncogene, 2003,22(38):6090\u20136099","journal-title":"Oncogene"},{"issue":"4","key":"2884_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1269\/jrr.45.473","volume":"45","author":"J Kobayashi","year":"2004","unstructured":"Kobayashi J. Molecular mechanism of the recruitment of NBS1\/hMRE11\/hRAD50 complex to DNA double-strand breaks: NBS1 binds to gamma-H2AXthrough FHA\/BRCT domain. J Radiat Res, 2004,45(4):473\u201347","journal-title":"J Radiat Res"},{"issue":"17","key":"2884_CR30","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1101\/gad.914401","volume":"15","author":"RT Abraham","year":"2001","unstructured":"Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes & Dev, 2001,15(17):2177\u20132196","journal-title":"Genes & Dev"},{"issue":"26","key":"2884_CR31","doi-asserted-by":"publisher","first-page":"14973","DOI":"10.1073\/pnas.96.26.14973","volume":"96","author":"R Khosravi","year":"1999","unstructured":"Khosravi R, Maya R, Gottlieb T, et al. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A, 1999,96(26):14973\u201314977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2884_CR32","doi-asserted-by":"publisher","first-page":"11655","DOI":"10.1038\/ncomms11655","volume":"7","author":"XJ Wang","year":"2016","unstructured":"Wang XJ, Chu HY, Lv MJ, et al. Structure of the intact ATM\/ Tel1 kinase. Nature Communications, 2016,7:11655","journal-title":"Nature Communications"},{"key":"2884_CR33","doi-asserted-by":"publisher","first-page":"107391","DOI":"10.1016\/j.pharmthera.2019.07.002","volume":"203","author":"MH Jin","year":"2019","unstructured":"Jin MH, Oh DY. ATM in DNA repair in cancer. Pharmacol Ther, 2019,203:107391","journal-title":"Pharmacol Ther"},{"issue":"4","key":"2884_CR34","first-page":"1667","volume":"53","author":"YQ Wang","year":"2018","unstructured":"Wang YQ, Yang LF, Zhang J, et al. Radiosensitization by irinotecan is attributed to G2\/M phase arrest, followed by enhanced apoptosis, probably through the ATM\/Chk\/Cdc25C\/Cdc2 pathway in p53-mutant colorectal cancer cells. Int J Oncol, 2018,53(4):1667\u20131680","journal-title":"Int J Oncol"},{"key":"2884_CR35","doi-asserted-by":"crossref","unstructured":"Wang Z, Lai ST, Ma NY, et al. Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair. Cancer Lett, 369(1):192\u2013201","DOI":"10.1016\/j.canlet.2015.08.015"},{"issue":"259","key":"2884_CR36","doi-asserted-by":"publisher","first-page":"259ra145","DOI":"10.1126\/scitranslmed.3010277","volume":"6","author":"Y Matsuo","year":"2014","unstructured":"Matsuo Y, Park JH, Miyamoto T, et al. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis. Sci Transl Med,2014,6(259):259ra145","journal-title":"Sci Transl Med"},{"issue":"4","key":"2884_CR37","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41418-020-00655-1","volume":"28","author":"KJ Herbert","year":"2021","unstructured":"Herbert KJ, Puliyadi R, Prevo R, et al. Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress. Cell Death Differ, 2021,28(4):1333\u20131346","journal-title":"Cell Death Differ"},{"key":"2884_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.dnarep.2018.07.005","volume":"69","author":"M Mirza-aghazadeh-attari","year":"2018","unstructured":"Mirza-aghazadeh-attari M, Darband SG, Kaviani M, et al. DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications. DNA Repair (Amst),2018,69:34\u201352","journal-title":"DNA Repair (Amst)"},{"issue":"1","key":"2884_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther, 2020,5(1):60","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"2884_CR40","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.3390\/cancers14194874","volume":"14","author":"S Deng","year":"2022","unstructured":"Deng S, Vlatkovic T, Li MY, et al. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer. Cancers (Basel), 2022,14(19):4874","journal-title":"Cancers (Basel)"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2884-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2884-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T04:08:06Z","timestamp":1719547686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2884-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2884"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2884-0","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}